Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Marketable Securities, Commodities & Short-Term by Quarter
Marketable Securities, Commodities & Short-Term Derivatives ($M)
Novartis Marketable Securities, Commodities & Short-Term: $105M in Q3 2026, down 46.7% from a year earlier.
Latest, Q3 2026
105
Period ended Sep 30, 2026
Change on a year earlier
-46.7%
197 in Q3 2025
History
6 quarters
Since Q4 2024
Sources
4
Documents cited below
Where the Q3 2026 figure comes from
“|| Marketable securities, time deposits and derivative financial instruments | 105 | 155”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Form 6-K.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Marketable Securities, Commodities & Short-Term Derivatives ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 105 | -46.7% | Novartis Form 6-K (0001114448-26-000014) ↗ |
| Q2 2026 | Jun 30, 2026 | 74 | – | Novartis Form 6-K (0001114448-26-000012) ↗ |
| Q1 2026 | Mar 31, 2026 | 100 | – | Novartis Form 6-K (0001114448-26-000010) ↗ |
| Q4 2025 | Dec 31, 2025 | 155 | -92.2% | Novartis Form 6-K (0001114448-26-000014) ↗ |
| Q3 2025 | Sep 30, 2025 | 197 | – | Novartis Form 6-K (0001114448-25-000003) ↗ |
| Q4 2024 | Dec 31, 2024 | 1,998 | – | Novartis Form 6-K (0001114448-25-000003) ↗ |
Cite this data
StockData. (2026). Novartis Marketable Securities, Commodities & Short-Term ($M), quarterly Q4 2024–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-bs-mkt-sec
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.